Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Authors:
Open Access
- 4 June 2020
- journal article
- research article
- Published by Wiley in Canadian Journal of Gastroenterology and Hepatology
- Vol. 2020, 1-9
Abstract
Background. Nonalcoholic fatty liver disease (NAFLD) may develop into liver cirrhosis and hepatocellular carcinoma (HCC). The aim of this study was to compare the clinical patterns and survival outcomes of NAFLD-related HCC patients and those of alcoholic liver disease (ALD)-related or hepatitis B virus (HBV)-related HCC patients. Methods. A total of 622 HCC patients with associated NAFLD (n = 56), ALD (n = 173), or HBV infection (n = 393) were enrolled. The clinical characteristics and survival were analyzed according to the underlying liver diseases. Results. NAFLD-related HCC patients were more commonly older women and had more metabolic risk factors but were less likely to have cirrhosis and ascites, compared to ALD-related or HBV-related HCC patients. NAFLD-related HCC more often had an infiltrative pattern (), a larger tumor (), more macrovascular invasion (), and exceeded the Milan criteria (), but was less frequently diagnosed during tumor surveillance (). Survival analysis did not show any difference among NAFLD-related, ALD-related, and HBV-related HCC patients. Furthermore, propensity score matching analysis did not reveal a significant difference in the median survival between the different groups (NAFLD vs. ALD, 14.0 months [95% confidence interval (CI), 2.0–26.0] vs. 13.0 months [95% CI, 0–26.3]; , NAFLD vs. HBV, 14.0 months [95% CI, 2.0–26.0] vs. 12.0 months [95% CI, 4.3–17.8]; ). Conclusions. NAFLD-related HCCs were more often detected at an advanced stage with infiltrative patterns, although they showed no significant difference in survival compared to ALD-related or HBV-related HCCs. A future prospective research should be focused on identifying NAFLD patients who require strict surveillance in order to early detect and timely treat HCC.
Keywords
Funding Information
- Dankook University (R201800083)
This publication has 29 references indexed in Scilit:
- Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and PreventionJournal of Clinical and Translational Hepatology, 2016
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menaceJournal of Hepatology, 2012
- Epidemiology and Surveillance of Hepatocellular CarcinomaLiver Cancer, 2012
- Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver diseaseHepatology, 2011
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Alcoholic Liver DiseaseHepatology, 2010
- Clinical features and outcomes of cirrhosis due to non‐alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis CJournal of Gastroenterology and Hepatology, 2009
- Non-alcoholic Steatohepatitis and CancerClinics in Liver Disease, 2007
- Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C†Hepatology, 2006
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999